ROSALYNN ANDERSON: Open Payments
NPI 1689188526 · RICHTON PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 37 payments from 10 companies in 2025. Trend: 2023 $512 · 2024 $246 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $261 |
| Janssen Pharmaceuticals, Inc | 11 | $222 |
| Neurocrine BioSciences, Inc. | 6 | $197 |
| Teva Pharmaceuticals USA, Inc. | 6 | $178 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
| Alkermes, Inc. | 1 | $14 |
Products named: VRAYLAR, INVEGA SUSTENNA, INGREZZA, AUSTEDO XR, UZEDY, REXULTI, FANAPT, APTIMA.
Industry payments across IL — which companies pay providers there.
